Telehealth GLP-1 Scams Persist Despite Government Settlement
Telehealth GLP-1 Scams Persist Despite Government Settlement
A Wired investigation has uncovered that customers are continuing to report fraudulent practices when purchasing compounded GLP-1 drugs—popular weight-loss and diabetes medications—through a telehealth network, despite the company having previously paid $5 million to settle related complaints with the US government.